MMV Call for Proposals: To receive technical assistance for Good Manufacturing Practices
Medicines for Malaria Venture (MMV) invites manufacturers of anti-malarial medicines to submit expressions of interest to receive technical assistance for Good Manufacturing Practices. Medicines for Malaria Venture (MMV) is committed to increasing the availability of quality-assured antimalarial drugs, in line with WHO treatment guidelines. In recognition of the importance of supporting the manufacturing of medicines closer to the patient, MMV is inviting manufacturers of Active Pharmaceutical Ingredients (API) for malaria medicines and Finished Pharmaceutical Products (FPP) to submit expressions of interest to receive technical assistance to support WHO prequalification for their products.
Eligible products for this program:
- You can find them in this link.
Selection criteria:
- Selection will be based on the following criteria: manufacturing facilities status, quality management system maturity, successful inspection and audit history, WHO/stringent regulatory agencies status, quality control laboratory capabilities, product portfolio, business sustainability.
Opportunity for Q&A:
- Manufacturers who have expressed interest and who wish to submit questions prior to the submission, are encouraged to do so by sending their questions to the following email address access@mmv.org. Responses to all questions will be posted on this page for all interested companies to see. on the MMV web site.
Read more here.
Expression of interest deadline September 29, 2023.
